Middle East & Africa Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)     

BMIRE00025068 | Pages: 188 | Pharmaceuticals | Jun 2022 | Type: Regional | Status: Published

The MEA dermatology OTC medications market is expected to grow from US$ 666.64 million in 2021 to US$ 792.34 million by 2028; it is estimated to grow at a CAGR of 2.5% from 2021 to 2028.

One of the dermatology OTC medications market's most visible trends is the shift of manufacturers from prescription pharmaceuticals toward over-the-counter products. Many manufacturers are shifting their products from Rx (prescription) to OTC. In its 2019 annual report, Bayer AG declared it would convert some of its prescriptive medications suitable for self-care to OTC as part of its strategy. This strategy is expected to increase the availability of OTC medications for a variety of illnesses in developing and developed countries. Rx-to-OTC is a feasible and enticing alternative for organizations seeking a life cycle extension strategy, enabling consumers to take control of their health. Transitioning to an OTC model may assist in maintaining target revenue and increasing a product's lifetime value. Furthermore, organizations with pharmaceutical and consumer health sections can readily implement the Rx-to-OTC approach. Moreover, Rx-to-OTC conversions offer significant benefits to patients, retailers, and manufacturers. Patients including the unique benefits of OTC drugs, such as lower costs and the opportunity to make treatment decisions without the involvement of doctors or insurers. Retailers gain from having more selections on their shelves, especially if the product is well known. As people spend more money on OTC products than on prescription drugs, there will be a tremendous need for OTC products in the future years.  

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA dermatology OTC medications market. The MEA dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

MEA Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

MEA Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Get more information on this report :


MEA Dermatology OTC Medications Market Segmentation         

 

The MEA dermatology OTC medications market is segmented intoproduct type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however, the oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020 and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is also segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020; however, the online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the MEA.     

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the MEA dermatology OTC medications market. 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Dermatology OTC Medications Market – By Product Type

1.3.2        MEA Dermatology OTC Medications Market – By Route of Administration

1.3.3        MEA Dermatology OTC Medications Market – By Indication

1.3.4        MEA Dermatology OTC Medications Market – By Distribution Channel

1.3.5        MEA Dermatology OTC Medications Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Dermatology OTC Medications Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Dermatology OTC Medications Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Surging Prevalence of Skin Problems

5.1.2        Escalating Income of Middle-class Population

5.2         Market Restraints

5.2.1        Inappropriate Use of OTC Medications

5.3         Market Opportunities

5.3.1        Accentuating OTC Market Across Various Countries

5.4         Future Trends

5.4.1        Burgeoning Transition from Rx to OTC

5.5         Impact Analysis of Drivers and Restraints

6.           Dermatology OTC Medications Market– MEA Analysis

6.1         MEA Dermatology OTC Medications Market Revenue Forecast and Analysis

7.           MEA Dermatology OTC Medications Market Analysis – By Product Type

7.1         Overview

7.2         MEA Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3         Tablets and Capsules

7.3.1        Overview

7.3.2        Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4         Gels

7.4.1        Overview

7.4.2        Gels Market Revenue and Forecast to 2028 (US$ million)

7.5         Creams and Ointments

7.5.1        Overview

7.5.2        Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6         Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ million)

8.           MEA Dermatology OTC medications Market Analysis – By Route of Administration

8.1         Overview

8.2         MEA Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3         Topical

8.3.1        Overview

8.3.2        Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.           MEA Dermatology OTC Medications Market Analysis – By Indication

9.1         Overview

9.2         MEA Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3         Dermatitis

9.3.1        Overview

9.3.2        Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3        Atopic Dermatitis

9.3.3.1          Overview

9.3.3.2          Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4        Contact Dermatitis

9.3.4.1          Overview

9.3.4.2          Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5        Others

9.3.5.1          Overview

9.3.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Acne

9.4.1        Overview

9.4.2        Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3        Non-Inflammatory Acne

9.4.3.1          Overview

9.4.3.2          Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4        Inflammatory Acne

9.4.4.1          Overview

9.4.4.2          Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5         Psoriasis

9.5.1        Overview

9.5.2        Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3        Plaque Psoriasis

9.5.3.1          Overview

9.5.3.2          Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4        Guttate Psoriasis

9.5.4.1          Overview

9.5.4.2          Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5        Others

9.5.5.1          Overview

9.5.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6         Skin Bleaching

9.6.1        Overview

9.6.2        Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7         Fungal Disease

9.7.1        Overview

9.7.2        Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3        Athlete's Foot

9.7.3.1          Overview

9.7.3.2          Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4        Ringworm

9.7.4.1          Overview

9.7.4.2          Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5        Fungal Nail Infections

9.7.5.1          Overview

9.7.5.2          Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6        Others

9.7.6.1          Overview

9.7.6.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8         Warts

9.8.1        Overview

9.8.2        Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3        Common Warts

9.8.3.1          Overview

9.8.3.2          Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4        Flat Warts

9.8.4.1          Overview

9.8.4.2          Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5        Others

9.8.5.1          Overview

9.8.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.        MEA Dermatology OTC medications Market Analysis – By Distribution Channel

10.1      Overview

10.2      MEA Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Offline Distribution

10.4.1     Overview

10.4.2     Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3     Retail and Hospital Pharmacies

10.4.3.1       Overview

10.4.3.2       Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4     Super and Hyper Markets

10.4.4.1       Overview

10.4.4.2       Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11.        MEA Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Country Analysis

11.1      MEA Medical Lasers Market Revenue and Forecasts To 2028

11.1.1     Overview

11.1.2     MEA Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)

11.1.3     UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.1       UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.2       UAE: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.3.3       UAE: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.3.4       UAE: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.3.4.1       UAE: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.3.4.2       UAE: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.3.4.3       UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.3.4.4       UAE: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.3.4.5       UAE: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.3.5       UAE: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.3.5.1       UAE: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.4     Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.4.1       Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.4.2       Saudi Arabia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4.3       Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.4.4       Saudi Arabia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.4.4.1       Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.4.4.2       Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.4.4.3       Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.4.4.4       Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.4.4.5       Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.4.5       Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.4.5.1       Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.5     South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.5.1       South Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.5.2       South Africa: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.5.3       South Africa: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.5.4       South Africa: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.5.4.1       South Africa: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.5.4.2       South Africa: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.5.4.3       South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.5.4.4       South Africa: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.5.4.5       South Africa: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.5.5       South Africa: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.5.5.1       South Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.6     Rest of the MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.6.1       Rest of MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.1.6.2       Rest of MEA: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.6.3       Rest of MEA: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.6.4       Rest of MEA: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.6.4.1       Rest of MEA: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.6.4.2       Rest of MEA: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.6.4.3       Rest of MEA: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.6.4.4       Rest of MEA: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.6.4.5       Rest of MEA: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.6.5       Rest of MEA: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.6.5.1       Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      Glossary of Terms

 


 

LIST OF TABLES

Table 1.             MEA Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             UAE: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             UAE: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             UAE: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             UAE: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 6.             UAE: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million).

Table 7.             UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          UAE: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 12.          Saudi Arabia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Saudi Arabia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 16.          Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 18.          Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 19.          Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 20.          Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.          Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 22.          South Africa: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          South Africa: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          South Africa: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          South Africa: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 26.          South Africa: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 27.          South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 28.          South Africa: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 29.          South Africa: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 30.          South Africa: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.          South Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of MEA: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 33.          Rest of MEA: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 34.          Rest of MEA: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of MEA: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of MEA: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of MEA: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 38.          Rest of MEA: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 39.          Rest of MEA: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 40.          Rest of MEA: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 41.          Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 42.          Recent Inorganic Growth Strategies

Table 43.          Recent Organic Growth Strategies

Table 44.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           MEA Dermatology OTC Medications Market Segmentation

Figure 2.           MEA Dermatology OTC Medications Market, By Country

Figure 3.           MEA Dermatology OTC Medications Market Overview

Figure 4.           Creams and Ointments Segment Held the Largest Share of the Market in 2021

Figure 5.           South Africa held the Largest Share of the Market in 2021

Figure 6.           MEA: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           MEA Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 9.           MEA Dermatology OTC Medications Market – By Forecast and Analysis

Figure 10.        MEA Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 11.        MEA Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 12.        MEA Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 13.        MEA Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 14.        MEA Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 15.        MEA Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 16.        MEA Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 19.        MEA Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        MEA Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        MEA Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        MEA Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        MEA Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.        MEA Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.        MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        MEA Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        MEA Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        MEA Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        MEA Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        MEA Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        MEA Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        MEA Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        MEA Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41.        MEA Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 42.        MEA Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43.        MEA Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44.        MEA Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45.        MEA Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46.        MEA Dermatology OTC Medications Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 47.        MEA Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)

Figure 48.        UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49.        Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50.        South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 51.        Rest of MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

  1. Bausch Health Companies Inc.
  2. Bayer AG
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S       
  8. Perrigo Company plc
  9. Viatris Inc.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA dermatology OTC medications market.         
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000